TABLE 1

PKA was not required for the rescue effect of A2A-R

Cells were transfected with an empty vector or a construct encoding p53-R175H or/and a construct encoding PKI along with a GFP vector as indicated. One day after transfection, cells were pretreated with or without H89 (10 μM) for 30 min before the addition of NGF (100 ng/ml), NGF plus CGS (1 μM), or NGF plus FK (10 μM) for 3 days. NGF-evoked neurite-bearing cells were quantified. Data represent the mean ± S.E.M. values from at least three independent experiments.

Cell CGS FK Inhibitor Neurite-Bearing Cells
Vector R175H
%
PC-12 35.4 ± 5.2 14.3 ± 3.2a
PC-12 + 42.2 ± 4.8 42.7 ± 6.5b
PC-12 + 39.7 ± 1.3 42.8 ± 9.8c
PC-12 PKI 34.6 ± 3.4 14.2 ± 3.6a
PC-12 + PKI 38.4 ± 1.8 39.0 ± 2.7b
PC-12 + PKI 38.8 ± 8.1 15.6 ± 3.8a
PC-12 H89 37.8 ± 4.9 11.4 ± 1.5a
PC-12 + H89 46.2 ± 0.8 44.4 ± 4.7b
A123 43.7 ± 1.5 22.7 ± 1.6a
A123 + 45.4 ± 4.0 45.1 ± 1.9b
  • +, with the indicated drug; −, without the indicated drug.

  • a Specific comparison between cells transfected with the indicated plasmid or a control vector (p < 0.001; two-way ANOVA).

  • b Specific comparison between cells treated with or without CGS (p < 0.001; two way ANOVA).

  • c Specific comparison between cells treated with or without FK (P < 0.001; two-way ANOVA).